• NatureSynthetic


Our Abpromise guarantee covers the use of ab45365 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • FormLiquid
  • Additional notes

    - First try to dissolve a small amount of peptide in either water or buffer. The more charged residues on a peptide, the more soluble it is in aqueous solutions.
    - If the peptide doesn’t dissolve try an organic solvent e.g. DMSO, then dilute using water or buffer.
    - Consider that any solvent used must be compatible with your assay. If a peptide does not dissolve and you need to recover it, lyophilise to remove the solvent.
    - Gentle warming and sonication can effectively aid peptide solubilisation. If the solution is cloudy or has gelled the peptide may be in suspension rather than solubilised.
    - Peptides containing cysteine are easily oxidised, so should be prepared in solution just prior to use.

  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

    Information available upon request.

General Info

  • Alternative names
    • A20
    • AISBL
    • MGC104522
    • MGC138687
    • MGC138688
    • OTU domain containing protein 7C
    • OTU domain-containing protein 7C
    • OTUD7C
    • Putative DNA binding protein A20
    • Putative DNA-binding protein A20
    • TNF alpha-induced protein 3
    • TNFA1P2
    • TNFAIP 3
    • TNFAIP3
    • TNFAIP3 (A20)
    • Tumor necrosis factor alpha induced protein 3
    • Tumor necrosis factor alpha-induced protein 3
    • Tumor necrosis factor induced protein 3
    • Tumor necrosis factor inducible protein A20
    • tumor necrosis factor, alpha-induced protein 3
    • Zinc finger protein A20
    see all
  • FunctionUbiquitin-editing enzyme that contains both ubiquitin ligase and deubiquitinase activities. Essential component of a ubiquitin-editing protein complex, comprising also RNF11, ITCH and TAX1BP1, that ensures the transient nature of inflammatory signaling pathways. Upon TNF stimulation, deubiquitinates 'Lys-63'-polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains. This leads to RIPK1 proteasomal degradation and consequently termination of the TNF- or LPS-mediated activation of NF-kappa-B. In vitro able to deubiquitinate both 'Lys-48'- and 'Lys-63' polyubiquitin chains. Inhibitor of programmed cell death. Has a role in the function of the lymphoid system.
  • Sequence similaritiesBelongs to the peptidase C64 family.
    Contains 7 A20-type zinc fingers.
    Contains 1 OTU domain.
  • DomainThe A20-type zinc fingers mediate the ubiquitin ligase activity.
    The OTU domain mediates the deubiquitinase activity.
  • Cellular localizationCytoplasm. Nucleus.
  • Information by UniProt

References for Human TNFAIP3 peptide (ab45365)

ab45365 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab45365.
Please use the links above to contact us or submit feedback about this product.